EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

The Role of Cadherin 17 (CDH17) in Cancer Progression via Wnt/β-Catenin Signalling Pathway: A Systematic Review and Meta-Analysis

Bipusha Tha Shrestha iD, Yahui Feng iD, Aaron Lad, Anthony Bates, Jing Chen iD, Karen Brown, Feier Zeng iD, Ning Wang iD

International Journal of Molecular Sciences · 10.10.2025 · 26 (20) · 9838

DOI: 10.3390/ijms26209838 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2025. Verfasst von Bipusha Tha Shrestha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Leicester Cancer Research Centre, School of Medical Sciences, University of Leicester, Leicester LE1 7LX, UK. Hauptthemen laut MEDLINE: Cadherins, Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Leicester, College of Life Sciences Centre PhD studentship, University of Leicester.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cadherin 17 (CDH17) is a cell adhesion glycoprotein essential for epithelial integrity. It is frequently overexpressed in various cancers, where it is associated with aggressive behaviour. While evidence indicates that CDH17 functions as an upstream regulator of Wnt/β-catenin signalling, findings are inconsistent across tumour types, limiting the assessment of CDH17 as a biomarker or therapeutic target for Wnt pathway in cancer. In this study, we systematically review and meta-analyse the relationship between CDH17 and Wnt/β-catenin signalling in human cancers and evaluate whether CDH17 modulation affects tumour behaviour through Wnt-related mechanisms. Our search of Medline, Web of Science and Scopus identified five studies examining CDH17 expression in the Wnt/β-catenin pathway in vitro and in vivo. All five studies identified CDH17 as a key driver of canonical Wnt signalling, directly influencing cancer progression in hepatocellular carcinoma (HCC), gastric cancer (GC), and colorectal cancer (CRC). Meta-analysis (MA) showed that CDH17 inhibition consistently reduced Wnt/β-catenin downstream T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) transcriptional activity (MD = −1.32, 95% CI: −1.64 to −0.99, p < 0.00001). Narrative synthesis found that CDH17 suppression decreased total and nuclear β-catenin, phosphorylated glycogen synthase kinase-3 beta (GSK-3β), and cyclin D1 while increasing tumour suppressors, retinoblastoma (Rb) and p53/p21. These changes were associated with reduced proliferation, colony formation, migration, invasion and cell cycle arrest. In vivo, CDH17 suppression resulted in 80–95% tumour growth suppression (Mean Difference (MD) = −96.67, 95% CI: [−144.35, −48.98], p < 0.0001), with immunohistochemistry confirming cytoplasmic β-catenin sequestration and lower cyclin D1 levels. Collectively, these findings show CDH17 as a critical upstream effector sustaining Wnt/β-catenin signalling, cancer progression, tumour proliferation, stem cell properties, and metastasis, and support CDH17 inhibition as a promising therapeutic target across multiple cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsNeoplasmsWnt Signaling PathwayAnimalsHumansbeta CateninCell ProliferationDisease ProgressionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CDH17TCF/LEFWnt/β-catenin signallingcancer progressiongastrointestinal cancer

Substanzen

beta CateninCadherinsCDH17 protein, human

Autor:innen und Institutionen

  • Leicester Cancer Research Centre, School of Medical Sciences, University of Leicester, Leicester LE1 7LX, UK.
  • Department of Biomedical Sciences, School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.
  • University Hospitals of Leicester, NHS Trust, Leicester LE1 5WW, UK.
  • Division of Epidemiology and Public Health, School of Medical Sciences, University of Leicester, Leicester LE1 7LX, UK.
  • Division of Clinical Medicine, The University of Sheffield, Sheffield S10 2RX, UK.

ORCID-Profile: Bipusha Tha Shrestha, Yahui Feng, Jing Chen, Feier Zeng, Ning Wang

Förderung

  • University of Leicester
  • College of Life Sciences Centre PhD studentship, University of Leicester

Zitieren

APA

Tha Shrestha, B., Feng, Y., Lad, A., Bates, A., Chen, J., Brown, K., Zeng, F., & Wang, N. (2025). The Role of Cadherin 17 (CDH17) in Cancer Progression via Wnt/β-Catenin Signalling Pathway: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 26(20), 9838. https://doi.org/10.3390/ijms26209838

Vancouver

Tha Shrestha B, Feng Y, Lad A, Bates A, Chen J, Brown K, et al. The Role of Cadherin 17 (CDH17) in Cancer Progression via Wnt/β-Catenin Signalling Pathway: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025;26(20):9838. doi:10.3390/ijms26209838

BibTeX
@article{ThaShrestha2025,
  author = {Tha Shrestha, Bipusha and Feng, Yahui and Lad, Aaron and Bates, Anthony and Chen, Jing and Brown, Karen and Zeng, Feier and Wang, Ning},
  title = {The Role of Cadherin 17 (CDH17) in Cancer Progression via Wnt/β-Catenin Signalling Pathway: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {9838},
  doi = {10.3390/ijms26209838}
}
Kostenlos starten →